Improving risk stratification models for patients with MGUS and smoldering myeloma Published 2022-05-24 Download video MP4 360p Download video MP4 720p Recommendations 22:44 How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar 05:34 How Is MGUS Monitored? 09:25 MGUS diagnosis: a step-by-step approach 22:50 My Multiple Myeloma Diagnosis: "They Weren't the Typical Symptoms" | Julie's Story 01:01 Targeting the N-myristoylation pathway to treat adult acute myeloid leukemia 07:36 MGUS and Smoldering Myeloma | Memorial Sloan Kettering 11:35 What is Monoclonal gammopathy of undetermined significance (MGUS)? | NCLEX-RN | Khan Academy 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 05:30 Changing perceptions of MGUS progression: explaining the data 03:47 what is MGUS? Is it cancer? How many people have MGUS, and how long can I have it? 06:43 Monoclonal Gammopathy & Peripheral Neuropathy 02:10 FDA approves promising treatment for multiple myeloma patients 05:54 Circulating Tumor Plasma Cells in the Screened iStopMM Smoldering Multiple Myeloma Cohort 03:33 The Role of Lifestyle on MGUS Progression | Betsy O’Donnell, MD | ASCO 2023 04:40 Understanding Parkinson’s Disease 21:56 Monoclonal Gammopathies: What you need to know 03:13 3 things to remember when diagnosing patients with MGUS 03:38 What are the signs and symptoms of multiple myeloma? 03:36 The PROMISE study: What have we learnt about MGUS prevalence and clinical implications? 17:39 THIS Is MUCH EASIER Than Fasting With Amazing Results Similar videos 05:04 The PANGEA model: improving risk stratification in multiple myeloma 01:33 Genomic profiling of smoldering myeloma to improve risk stratification models 00:57 Risk stratification in multiple myeloma 00:24 Risk Stratification for MGUS | Dr. S. Vincent Rajkumar | Oncology Brothers 07:44 Smoldering Myeloma: Treatment and Risk Stratification 13:42 Basics of MGUS and Smoldering Myeloma - Shaji Kumar, MD | MCRT Webcast September 26 (1/3) 01:11 The PANGEA model: enhancing risk assessment for individuals with high-risk smoldering myeloma 04:12 When should smoldering multiple myeloma patients start treatment? 01:44 Is there a clear definition for standard-risk smoldering myeloma? 49:36 Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention 03:16 Should smoldering myeloma patients start treatment? 06:54 Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study 1:02:06 Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action 02:18 Preventing progression: smoldering myeloma 02:07 Redefining risk stratification in multiple myeloma 28:51 Diagnosis and Risk Stratification of Plasma Cell Disorders (pt 1 of 5 - IMF ASH Satellite) 02:45 Clinical and genomic diagnosis of smoldering myeloma & identifying patients at risk of progression 00:43 The importance of improving precision when risk stratifying patients with multiple myeloma 30:34 Smoldering multiple myeloma: Early detection and intervention approaches by Dr. Mark Bustoros More results